Recommendations for the use of antiemetics: Evidence-based, clinical practice guidelines

被引:400
作者
Gralla, RJ [1 ]
Osoba, D [1 ]
Kris, MG [1 ]
Kirkbride, P [1 ]
Hesketh, PJ [1 ]
Chinnery, LW [1 ]
Clark-Snow, R [1 ]
Gill, DP [1 ]
Groshen, S [1 ]
Grunberg, S [1 ]
Koeller, JM [1 ]
Morrow, GR [1 ]
Perez, EA [1 ]
Silber, JH [1 ]
Pfister, DG [1 ]
机构
[1] Amer Soc Clin Oncol, Alexandria, VA 22314 USA
关键词
D O I
10.1200/JCO.1999.17.9.2971
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:2971 / 2994
页数:24
相关论文
共 291 条
  • [1] METHODOLOGICAL ISSUES IN ANTIEMETIC STUDIES
    AAPRO, M
    [J]. INVESTIGATIONAL NEW DRUGS, 1993, 11 (04) : 243 - 253
  • [2] THE INCIDENCE OF ANTICIPATORY NAUSEA AND VOMITING AFTER REPEAT CYCLE CHEMOTHERAPY - THE EFFECT OF GRANISETRON
    AAPRO, MS
    KIRCHNER, V
    TERREY, JP
    [J]. BRITISH JOURNAL OF CANCER, 1994, 69 (05) : 957 - 960
  • [3] AAPRO MS, 1981, CANCER CHEMOTH PHARM, V7, P11
  • [4] COSTS AND BENEFITS OF ANTIEMETIC THERAPY
    AAPRO, MS
    [J]. SUPPORTIVE CARE IN CANCER, 1994, 2 (05) : 304 - 306
  • [5] DOUBLE-BLIND CROSSOVER STUDY OF THE ANTIEMETIC EFFICACY OF HIGH-DOSE DEXAMETHASONE VERSUS HIGH-DOSE METOCLOPRAMIDE
    AAPRO, MS
    PLEZIA, PM
    ALBERTS, DS
    GRAHAM, V
    JONES, SE
    SURWIT, EA
    MOON, TE
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (05) : 466 - 471
  • [6] Abbott Beverly, 1996, Blood, V88, p252B
  • [7] PHASE-I/II TRIAL OF GRANISETRON - A NOVEL 5-HYDROXYTRYPTAMINE ANTAGONIST FOR THE PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING
    ADDELMAN, M
    ERLICHMAN, C
    FINE, S
    WARR, D
    MURRAY, C
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (02) : 337 - 341
  • [8] AGURA ED, 1995, BONE MARROW TRANSPL, V16, P213
  • [9] ALAVI JB, 1984, P AN M AM SOC CLIN, V3, P109
  • [10] ALBA E, 1989, ONCOLOGY, V46, P26